Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics
J Gen Intern Med
Epub 2019 Oct 17.
Sanket S Dhruva
Nilay D Shah
Joseph S Ross
Yale University School of Medicine, New Haven, CT, USA.
Department of Medicine, Johns Hopkins Hospital, Johns Hopkins School of Medicine, Baltimore, MD, USA.
San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
San Francisco School of Medicine, University of California, San Francisco, CA, USA.
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
Division of Health Care Policy and Research, Mayo Clinic, Rochester, MN, USA.
Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT, USA. firstname.lastname@example.org.
Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA. email@example.com.
Department of Health Policy and Management, Yale University School of Public Health, New Haven, CT, USA. firstname.lastname@example.org.
No abstract available
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
Medicare Part D*
U01 FD004585/FD/FDA HHS/United States
R03 HS025517/HS/AHRQ HHS/United States
R56 HL130496/HL/NHLBI NIH HHS/United States
UL1 TR001863/TR/NCATS NIH HHS/United States
R01 HS025164/HS/AHRQ HHS/United States
R01 HS025402/HS/AHRQ HHS/United States
R01 HS022882/HS/AHRQ HHS/United States
R01 HL131535/HL/NHLBI NIH HHS/United States
U01 FD005938/FD/FDA HHS/United States